The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Rash and diarrhea with afatinib treatment in metastatic adenocarcinoma lung cancer patients (pts) unselected for epidermal growth factor receptor (EGFR) mutations: Retrospective study.
Maria Rita Migliorino
No relevant relationships to disclose
Stefano De Santis
No relevant relationships to disclose
Alberto Fulvi
No relevant relationships to disclose
Daniela Soregaroli
No relevant relationships to disclose
Antonio Passaro
No relevant relationships to disclose
Serena Ricciardi
No relevant relationships to disclose